Antinociceptive local activity of 4-allyl-1-hydroxy2-methoxybenzene (eugenol) by the formalin test: an anti-inflammatory effect
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/164741 |
Resumo: | Eugenol has been employed for decades as a condiment, an antimycotic, an antibacterial, an antiviral, and an antioxidant, and it is one of the natural analgesics most frequently utilized for pain and inflammation. Our objective was to determine the analgesic/anti-inflammatory effect of eugenol compared with diclofenac, naproxen, and tramadol using the formalin test. The formalin method was used in 6- to 10-week-old Wistar rats (weighing 250 g each) divided into six groups: saline (0.9%); formalin (5%); diclofenac (250 µg/kg); naproxen (400 µg/kg); tramadol (500 µg/kg), and eugenol (1,400 µg/kg), in the intraplantar part of the hind-end trunk of the rats, with n = 5 per group. Eugenol diminished 44.4% of nociceptive behavior in phase 1 and 48% in phase 2 (p ≤0.05 vs formalin). Eugenol was shown to be 1.14 times more effective than diclofenac, but 1.62 and 1.75 times less effective than naproxen and tramadol, respectively, in phase 1 and 1.45 times less effective than diclofenac and naproxen and 1.66 less effective than tramadol in phase 2 (p ≤0.05). These data suggest that eugenol possesses moderate activity in the acute pain phase and greater activity in inflammatory-type pain, and both effects are comparable to those produced by diclofenac and are less than the effects produced by naproxen and tramadol in the formalin test. |
id |
USP-31_75129323c5d68e4e2b9d22067048053b |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/164741 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
Antinociceptive local activity of 4-allyl-1-hydroxy2-methoxybenzene (eugenol) by the formalin test: an anti-inflammatory effectEugenol/analgesic/anti-inflammatory effectDiclofenac effectAntinociceptionFormalin testPainEugenol has been employed for decades as a condiment, an antimycotic, an antibacterial, an antiviral, and an antioxidant, and it is one of the natural analgesics most frequently utilized for pain and inflammation. Our objective was to determine the analgesic/anti-inflammatory effect of eugenol compared with diclofenac, naproxen, and tramadol using the formalin test. The formalin method was used in 6- to 10-week-old Wistar rats (weighing 250 g each) divided into six groups: saline (0.9%); formalin (5%); diclofenac (250 µg/kg); naproxen (400 µg/kg); tramadol (500 µg/kg), and eugenol (1,400 µg/kg), in the intraplantar part of the hind-end trunk of the rats, with n = 5 per group. Eugenol diminished 44.4% of nociceptive behavior in phase 1 and 48% in phase 2 (p ≤0.05 vs formalin). Eugenol was shown to be 1.14 times more effective than diclofenac, but 1.62 and 1.75 times less effective than naproxen and tramadol, respectively, in phase 1 and 1.45 times less effective than diclofenac and naproxen and 1.66 less effective than tramadol in phase 2 (p ≤0.05). These data suggest that eugenol possesses moderate activity in the acute pain phase and greater activity in inflammatory-type pain, and both effects are comparable to those produced by diclofenac and are less than the effects produced by naproxen and tramadol in the formalin test.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2019-12-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/16474110.1590/s2175-97902019000118022Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e18022Brazilian Journal of Pharmaceutical Sciences; v. 55 (2019); e18022Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e180222175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/164741/157939Copyright (c) 2019 Brazilian Journal of Pharmaceutical Scienceshttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessLugo-Lugo, Daniela ElizabethPozos-Guillén, Amaury de JesúsZapata-Morales, Juan RamónRodríguez-Chong, AntonioRangel-López, Azahel de JesúsSaavedra-Leos, María ZenaidaVértiz-Hernández, Angel Antonio2021-01-11T18:11:47Zoai:revistas.usp.br:article/164741Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2021-01-11T18:11:47Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Antinociceptive local activity of 4-allyl-1-hydroxy2-methoxybenzene (eugenol) by the formalin test: an anti-inflammatory effect |
title |
Antinociceptive local activity of 4-allyl-1-hydroxy2-methoxybenzene (eugenol) by the formalin test: an anti-inflammatory effect |
spellingShingle |
Antinociceptive local activity of 4-allyl-1-hydroxy2-methoxybenzene (eugenol) by the formalin test: an anti-inflammatory effect Lugo-Lugo, Daniela Elizabeth Eugenol/analgesic/anti-inflammatory effect Diclofenac effect Antinociception Formalin test Pain |
title_short |
Antinociceptive local activity of 4-allyl-1-hydroxy2-methoxybenzene (eugenol) by the formalin test: an anti-inflammatory effect |
title_full |
Antinociceptive local activity of 4-allyl-1-hydroxy2-methoxybenzene (eugenol) by the formalin test: an anti-inflammatory effect |
title_fullStr |
Antinociceptive local activity of 4-allyl-1-hydroxy2-methoxybenzene (eugenol) by the formalin test: an anti-inflammatory effect |
title_full_unstemmed |
Antinociceptive local activity of 4-allyl-1-hydroxy2-methoxybenzene (eugenol) by the formalin test: an anti-inflammatory effect |
title_sort |
Antinociceptive local activity of 4-allyl-1-hydroxy2-methoxybenzene (eugenol) by the formalin test: an anti-inflammatory effect |
author |
Lugo-Lugo, Daniela Elizabeth |
author_facet |
Lugo-Lugo, Daniela Elizabeth Pozos-Guillén, Amaury de Jesús Zapata-Morales, Juan Ramón Rodríguez-Chong, Antonio Rangel-López, Azahel de Jesús Saavedra-Leos, María Zenaida Vértiz-Hernández, Angel Antonio |
author_role |
author |
author2 |
Pozos-Guillén, Amaury de Jesús Zapata-Morales, Juan Ramón Rodríguez-Chong, Antonio Rangel-López, Azahel de Jesús Saavedra-Leos, María Zenaida Vértiz-Hernández, Angel Antonio |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Lugo-Lugo, Daniela Elizabeth Pozos-Guillén, Amaury de Jesús Zapata-Morales, Juan Ramón Rodríguez-Chong, Antonio Rangel-López, Azahel de Jesús Saavedra-Leos, María Zenaida Vértiz-Hernández, Angel Antonio |
dc.subject.por.fl_str_mv |
Eugenol/analgesic/anti-inflammatory effect Diclofenac effect Antinociception Formalin test Pain |
topic |
Eugenol/analgesic/anti-inflammatory effect Diclofenac effect Antinociception Formalin test Pain |
description |
Eugenol has been employed for decades as a condiment, an antimycotic, an antibacterial, an antiviral, and an antioxidant, and it is one of the natural analgesics most frequently utilized for pain and inflammation. Our objective was to determine the analgesic/anti-inflammatory effect of eugenol compared with diclofenac, naproxen, and tramadol using the formalin test. The formalin method was used in 6- to 10-week-old Wistar rats (weighing 250 g each) divided into six groups: saline (0.9%); formalin (5%); diclofenac (250 µg/kg); naproxen (400 µg/kg); tramadol (500 µg/kg), and eugenol (1,400 µg/kg), in the intraplantar part of the hind-end trunk of the rats, with n = 5 per group. Eugenol diminished 44.4% of nociceptive behavior in phase 1 and 48% in phase 2 (p ≤0.05 vs formalin). Eugenol was shown to be 1.14 times more effective than diclofenac, but 1.62 and 1.75 times less effective than naproxen and tramadol, respectively, in phase 1 and 1.45 times less effective than diclofenac and naproxen and 1.66 less effective than tramadol in phase 2 (p ≤0.05). These data suggest that eugenol possesses moderate activity in the acute pain phase and greater activity in inflammatory-type pain, and both effects are comparable to those produced by diclofenac and are less than the effects produced by naproxen and tramadol in the formalin test. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-12-03 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/164741 10.1590/s2175-97902019000118022 |
url |
https://www.revistas.usp.br/bjps/article/view/164741 |
identifier_str_mv |
10.1590/s2175-97902019000118022 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/164741/157939 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2019 Brazilian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2019 Brazilian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e18022 Brazilian Journal of Pharmaceutical Sciences; v. 55 (2019); e18022 Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e18022 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1800222914475196416 |